BENDAMUSTINE HYDROCHLORIDE
Active substance: Bendamustine
INJECTION · BENDAMUSTINE HYDROCHLORIDE 100 mg/1
United StatesActive
Marketing holder: Baxter Healthcare Corporation
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- BENDAMUSTINE HYDROCHLORIDE · 100 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-3be9-7bc9-ba65-9291b7eed109,01a1208e-1058-7868-9dcc-583bc2977dbc,01a1208e-7724-74ee-ace8-0b10293a33f5,01a1208e-ea9d-71e8-9869-6d71946989c0,01a1208f-9288-79ca-b4f7-4decad15a189;count=17 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 10019-079
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 10019-079 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 10019-079 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 10019-079 · Verified 2026-10-09 · open in source